← FDA DRUG APPROVALS

FDA BLA · BLA761212

ARMLUPEG

pegfilgrastim-unne

Sponsor: LUPIN LTD

APPLICATION
BLA761212
TYPE
BLA
ORIGINAL APPROVAL
2025-11-28
LATEST ACTION
2025-11-28
ROUTE
SUBCUTANEOUS, SOLUTION
DOSAGE FORM
INJECTION
MARKETING STATUS
Prescription

Products

ARMLUPEGPrescription
PEGFILGRASTIM-UNNE 6MG/0.6ML · INJECTION · SOLUTION

Approval history

2025-11-28UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Biologics industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →